Cellcept 250 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FG9TL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,577
Award facts
- Contract value 100% obligated
- $7,577.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,577.14 to AmerisourceBergen Drug Corp for the supply of CellCept 250 mg capsules (100 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. CellCept (mycophenolate mofetil) is an immunosuppressant medication commonly used in military and veteran healthcare systems for organ transplant recipients and patients with certain autoimmune conditions.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency and military healthcare programs globally. The company's large IDC vehicle demonstrates its established capability to meet federal medical supply requirements and support the military healthcare supply chain across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FG9TL?
SPE2DB25FG9TL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FG9TL worth?
The government has obligated $7,577 on SPE2DB25FG9TL.
Is contract SPE2DB25FG9TL an order under another contract?
Yes. SPE2DB25FG9TL is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FG9TL competed?
The extent of competition for SPE2DB25FG9TL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award